[Skip to Content]
Diabetic Retinopathy

Randomized Trial of Anti-VEGF to Prevent Proliferative Diabetic Retinopathy (PDR) and Diabetic Macular Edema (DME)

JAMA Ophthalmology
Published Online: March 30, 2021 Audio Author Interview 18 min 29 sec
<title>Randomized Trial of Anti-VEGF to Prevent Proliferative Diabetic Retinopathy (PDR) and Diabetic Macular Edema (DME)</title>
Backward 15 Play Pause Forward 15
1x
0:00 / 0:00
Download MP3

Interview with Raj K Maturi, MD, and Jennifer K Sun, MD, authors of Randomized Clinical Trial of Anti-VEGF to Prevent PDR and CI-DME and with Howard Bauchner, MD, Editor in Chief of JAMA

Subscribe

Subscribe on your favorite podcast source to receive future episodes of this podcast.
Learn more about this JAMA Network podcast here

Related Articles

  1. Randomized Clinical Trial of Anti-VEGF to Prevent PDR and CI-DME
    1.00 CME

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

See More About

Diabetic Retinopathy Ophthalmology Diabetes Diabetes and Endocrinology Macular Diseases Retinal Disorders
Close
Close

Name Your Search

Save Search
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue